Stock Taper
Fractyl Health, Inc. develops therapies like the Revita DMR System and Rejuva gene platform to treat type 2 diabetes and obesity by durably modifying duodenal dysfunction and pancreatic hormone function.

The Revita DMR System is an outpatient medical device that performs duodenal mucosal resurfacing to improve glucose control and support weight loss in metabolic conditions like type 2 diabetes and obesity.
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
ARTV | $11.30 | COMPARE |
ALXO | $2.02 | COMPARE |
STRO | $20.21 | COMPARE |
BMEA | $1.99 | COMPARE |
DTIL | $7.47 | COMPARE |
ATYR | $0.50 | COMPARE |
MGX | $1.17 | COMPARE |
QNCX | $30.21 | COMPARE |